Article Details

AstraZeneca Revenue Hurt as Demand for COVID-19 Treatments Slumps; Stock Drops

Retrieved on: 2024-02-08 19:49:07

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Revenue Hurt as Demand for COVID-19 Treatments Slumps; Stock Drops. View article details on hiswai:

Excerpt

AstraZeneca PLC missed Q4 profit forecasts as its revenue was slowed by falling demand for COVID-19 vaccines and medicines.

Article found on: www.investopedia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up